After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition
Jul 03, 2021
New Delhi [India], : Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group...